Belite Bio (BLTE) Return on Capital Employed (2023 - 2025)
Belite Bio's (BLTE) quarterly Return on Capital Employed came in at 2978301.27% in Q4 2025, down 296360610.0% year-on-year from N/an in Q4 2024, and up 59.48% quarter-over-quarter from 7350732.03% in Q3 2025.
Belite Bio (BLTE) Return on Capital Employed (2023 - 2025) Analysis & Trends
Belite Bio's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 2978301.27% for Q4 2025.
- On a quarterly basis, Return on Capital Employed fell 296360610.0% year-over-year to 2978301.27% in Q4 2025; TTM through Dec 2025 was 2978301.27%, a 296360610.0% decrease from a year earlier, with the FY2025 full-year figure at 18.45%, up 1564.0% from the prior year.
- Return on Capital Employed grew to 2978301.27% in Q4 2025 per BLTE's latest filing, from 7350732.03% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 14695.17% in Q4 2024 and bottomed at 7350732.03% in Q3 2025.
- The 3-year median for Return on Capital Employed is 1498648.83% (2023), against an average of 2590681.22%.
- Across the five-year window, Return on Capital Employed jumped 430122 bps in 2024 and plunged 296360610 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 18996.39% in 2023, then rose by 23 bps to 14695.17% in 2024, then slumped by 20167 bps to 2978301.27% in 2025.
- Per Business Quant, the three latest BLTE Return on Capital Employed figures stand at 2978301.27% (Q4 2025), 7350732.03% (Q3 2025), and 14695.17% (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -68.84% |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 20.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,978,301.27% |
| Sep 30, 2025 | -7,350,732.03% |
| Dec 31, 2024 | -14,695.17% |
| Dec 31, 2023 | -18,996.39% |